| Spotlight |
 |
|
CSL said the investment reflects the growing need for immunoglobulin, though it did not reveal detailed manufacturing plans.
|
| Latest news |
|
|
The approval follows evaluation of data from the Phase III Aspen and Phase II Willow studies.
|
|
|
At two upcoming events, experts will offer practical solutions to key challenges for oncology and rare disease clinical trials.
|
|
|
Amanda Murphy, Senior Director at GlobalData, discusses how real-time intelligence can turns regulatory events into opportunities.
|
|
|
Genprex is advancing additional applications in Canada, China, Brazil, Europe and Israel.
|
|
|
In a year where ADC deals have showed no signs of slowing, Solve has become the latest biotech to unlock an extra slice of capital.
|
|
|
|
